Kintara Therapeutics Inc. buy melinda
Start price
29.09.20
/
50%
€1.21
Target price
04.11.21
€1.80
Performance (%)
-18.78%
End price
13.10.21
€0.99
Summary
This prediction ended on 13.10.21 with a price of €0.99. The prediction for Kintara Therapeutics Inc. disappointed with a performance of -18.78%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Kintara Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
According to melinda what are the pros and cons of Kintara Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Delmar Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 1,8
In the thread Trading Delmar Pharmaceuticals Inc.
Buy beendet
Stopped prediction by melinda for Kintara Therapeutics Inc.
Kintara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.081
09.04.23
09.04.23
€0.15
-
02.05.23
02.05.23
Could be worthwhile Investment >10% per year
Kintara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.99
13.10.21
13.10.21
€1.50
13.10.22
13.10.22
-23.86%
24.10.21
24.10.21
Could be worthwhile Investment >10% per year